If you deal with recurrent UTIs, a new FDA-approved antibiotic called Blujepa could offer another treatment option—especially ...

Various factors seem to have contributed to 23andMe’s decline. Its kits are a one-time product, so there is little prospect ...

Camden has some of the worst pollution hotspots in London - its air contains 24% higher levels of pollutants than the UK ...

In a statement yesterday, GSK’s board said that Slaoui’s dismissal was effective immediately, a decision triggered by a letter received last month from an employee containing allegations of ...

Shares in Moderna and Novavax fell Monday, following a Wall Street Journal report that the Food and Drug Administration’s top vaccine official has been pushed out. Shares in some larger drugmakers, ...

An antibody-drug conjugate (ADC) that GSK licensed from China's Hansoh Pharma in a $1.7 billion deal last year has been given breakthrough status by the FDA. The coveted designation for GSK5764227 ...

HIGHLIGHTS Recent exploration by Novo at the Clone prospect included detailed structural, lithological and regolith mapping, ...

AstraZeneca has vowed to spend over $10 billion on R&D deals in Asia, focusing on China, amid ongoing fraud scandal ...

Major drugmakers tumble as Wall Street braces for new tariffs with potential implications for the pharma industry. Read more here.